AZELAIC ACID
| Brand name | FINACEA |
|---|---|
| Active ingredient | AZELAIC ACID |
| Strength | 15% |
| Dosage form | AEROSOL, FOAM |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | July 2015 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9211259 | February 2029 | use U-1796 |
| 9265725 | December 2027 | product |
| 10117812 | October 2027 | product |
| 7700076 | September 2027 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.